EGF-conjugated liposomes significantly decreased the IC50 of oxaliplatin in EGFR-positive colorectal cancer cell lines without enhancing the cytotoxicity of oxaliplatin in EGFR-negative colorectal cancer cell lines 39. This evidence concerns the gene EGF and colorectal cancer.